AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK
AQEMIA, a pioneering techbio that teaches atomic scale physics to a generative AI to invent innovative medicines, announces two major milestones: $100 million in cumulative funding and the beginning of a global expansion starting with London (United Kingdom).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210380168/en/
Maximilien Levesque, CEO and Cofounder of AQEMIA (left) and Emmanuelle Martiano Rolland, COO and Cofounder of AQEMIA (Photo: Business Wire)
The new $38 million funding round, led by new investor Cathay Innovation, brings total funds raised since inception to over $100 million. This round, coming less than a year after the previous one, follows the successful validation of AQEMIA’s drug discovery platform through outstanding results in internal preclinical programs and pharmaceutical partnerships, particularly in oncology. The funding will support AQEMIA’s development goals, including preparations for clinical trials.
“This is a transformative moment for AQEMIA,” said Maximilien Levesque, PhD, CEO and co-founder of AQEMIA. “Less than a year after our last round, this successful fundraising and the opening of our new London office mark significant strides toward our ambition to accelerate the discovery of new medicines on a global scale. Partnering with Cathay Innovation brings international expertise, particularly in the US and Asia, reinforcing our vision and mission. With this momentum, we are poised to advance to clinical trials, bringing us closer to delivering life-changing treatments to patients in need.”
This new round is led by Cathay Innovation, followed by historical investors Wendel, Bpifrance Large Venture, Eurazeo, and Elaia.
“We have long been committed to supporting visionary entrepreneurs who harness the transformative potential of AI to reshape the healthcare industry,”supports Jacky Abitbol, partner at Cathay Innovation. “AQEMIA embodies the future of drug discovery, combining the power of AI with quantum mechanics. Fueled by Maximilien and Emmanuelle, the company’s vision is one that is fully aligned with Cathay Innovation’s DNA, as it aims to profoundly transform the molecule research and pharmaceutical industry as a whole. Our partnership goes beyond capital support; we are putting to good use our experience in scaling AI-driven companies all over the world, particularly across US and Asia, as AQEMIA accelerates its path to the clinic and expands its global impact.”
In addition to reaching the $100 million funding milestone, AQEMIA announces the opening of its London office, scheduled for January 2025 in the King’s Cross area. This expansion strengthens AQEMIA’s presence in the UK’s dynamic tech and biotech sectors. The new location will provide access to the UK’s rich talent pool, especially in life sciences and techbio, as the company continues its global recruitment efforts across all levels.
AQEMIA will also use the proceeds to continue to advance its technology platform—teaching quantum-inspired, atomic-scale physics to generative AI—to transform drug discovery, designing innovative and safe small-molecule drugs with high efficiency. By teaching theoretical physics to the generative AI, AQEMIA does not need experimental data to train on, unlocking truly innovative molecular designs, further away from existing molecules—a key challenge for genAI today. The drug discovery platform is now proven to work, as demonstrated by AQEMIA’s recent preclinical successes: (i) in their most advanced oncology programs with in vivo results, which continue to progress toward clinical trials, and (ii) through AQEMIA’s $140 million collaboration with Sanofi, announced in December 2023, which already underscored the platform's potential and strong industry recognition.
About AQEMIA
AQEMIA is a next-gen Techbio company building one of the world's fastest-growing drug discovery pipelines. Our mission is to rapidly design innovative drug candidates for critical diseases. What sets us apart is our unique use of physics and statistical mechanics algorithms to power generative AI, enabling the design of novel drug candidates without relying on experimental data. We have already achieved several drug discovery successes within our internal pipeline and through collaborations with leading pharmaceutical companies, with our most advanced programs currently undergoing in vivo optimization.
For more information, visit AQEMIA.com and our LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20241210380168/en/


Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
24,000 Registered Attendees Fill the Halls of Successful SPIE Photonics West 202510.2.2025 20:55:00 CET | Press release
The largest annual optics and photonics event of the year highlighted exciting new research, networking, and the latest in photonics products and industry trends SPIE, the international society for optics and photonics, registered 24,000 optics and photonics professionals from over 75countries for Photonics West, as the Society hosted the largest international annual photonics meeting at San Francisco’s Moscone Center. The dynamic week, which ran from 25 to 30 January, featured 1,588 exhibitors and 5,000 technical presentations across four focused tracks – BiOS, LASE, OPTO, Quantum West – four exhibitions, and the co-located AR | VR | MR conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210056991/en/ SPIE Photonics West 2025 exhibition opens for business at San Francisco's Moscone Center. (Photo: Business Wire) “Photonics West marks the start of the optics and photonics calendar every year,” said SPIE CEO Kent Ro
Dubai Electricity and Water Authority PJSC Announces Record Annual Revenue of AED 30.98 Billion and an Unprecedented EBITDA of AED 15.70 Billion for the Year 202410.2.2025 16:49:00 CET | Press release
Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210262973/en/ HE Saeed Mohammed Al Tayer, MD & CEO of DEWA. (Photo: AETOSWire). Full Year 2024* Q4, 2024* AED 30.98 billion AED 15.70 billion AED 7.45 billion AED 3.95 billion +6.18% YoY +6.25% YoY +6.13% YoY +11.11% YoY vs. 2023 Revenue vs. 2023 EBITDA vs. Q4, 2023 Revenue vs. Q4, 2023 EBITDA *Figures are rounded. Ratios are based on actuals. Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), the Emirate of Dubai’s exclusive electricity and water services provider, which is listed on the Dubai Financial Market (DFM), today reported its full year 2024 preliminary and unaudited consolidated financial results. DEWA Group recorded consolidated full year revenue of AED 30.98 billion, EBITDA of AED 15.70 billion and net profit after tax of AED 7.24 billion. For Q4, 2024, DE
ShadowDragon Sets a New Standard in Link Analysis, Monitoring, & OSINT by Launching Multilingual Suite10.2.2025 16:21:00 CET | Press release
ShadowDragon Horizon - Empowering Global Investigations in Spanish, French, Italian, German—and More Languages on the Horizon ShadowDragon, a leader in digital investigations and open-source intelligence (OSINT) solutions, today announced the launch of Horizon in multiple languages. Effective immediately, this flagship tool—previously available in English—is now fully localized in Spanish, French, Italian, and German, with additional languages slated for release in the coming months. By expanding language support, ShadowDragon becomes the first in the industry to offer a comprehensive suite of advanced OSINT capabilities designed to serve a wide range of global investigators, law enforcement, and intelligence agencies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207507777/en/ “ShadowDragon has always led the way in building robust OSINT solutions that keep pace with today’s complex global landscape,” said Daniel Clemen
AV’s JUMP 20 Selected by Danish Defence Acquisition and Logistics Organisation for Tactical UAS Program of Record10.2.2025 15:10:00 CET | Press release
AeroVironment (AV), through its wholly owned subsidiary Arcturus UAV, has been awarded a contract by the Danish Defence Acquisition and Logistics Organisation (DALO) with a contract ceiling value of $181 million to deliver the JUMP® 20 medium uncrewed aircraft system (UAS) to the Danish Armed Forces. This 10-year program of record will equip the Danish Army with JUMP 20 systems to enhance intelligence, surveillance, and reconnaissance (ISR) operations, reinforcing AV’s position as a global leader in advanced autonomous solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210680163/en/ AV to supply its JUMP 20 uncrewed aircraft system to the Danish Armed Forces through new program of record (Photo: AeroVironment) JUMP 20 is a vertical take-off and landing (VTOL), fixed-wing UAS with 13+ hours of endurance and an operational range of 185 km (115 mi). Runway independent, the system is easily storable and transportable,
Tigo Energy Expands Predict+ for Utility Analytics as Platform Approaches 10X Annual Growth10.2.2025 15:00:00 CET | Press release
Predict+ platform surpasses 140,000 meters under management globally, expands advanced feature set, and brings machine learning-powered energy consumption and production prediction to utilities in Europe and North America. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo”), a leading provider of intelligent solar and energy software solutions, today announced a set of powerful enhancements to the Predict+ platform that gives utilities deep insight into grid demand, renewable generation, and energy market dynamics. Designed to enhance the accuracy, scalability, and robustness of energy forecasting with up to 97.5% accuracy through machine learning and artificial intelligence, the platform leverages smart meter consumption data to predict precise grid production and consumption forecasts. Predict+ helps energy providers streamline operations, reduce volatility, and maximize performance. Since the first quarter of 2024, the Predict+ platform has grown from 15,000 to 140,000 meters under management
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom